Hap Trading, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	BUY	$40.86 - $57.65 $3.02 Million - $4.26 Million	73,953 Added 415.49%	91,752 $5 Million
Q3 2019 Nov 12, 2019	BUY	$37.38 - $49.47 $665,326 - $880,516	17,799 New	17,799 $743,000
Q2 2018 Aug 13, 2018	SELL	$23.62 - $42.29 $475,872 - $852,016	-20,147 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$22.49 - $34.56 $453,106 - $696,280	20,147 New	20,147 $519,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.